EUVIMEDEUVIMED entdecken
Systematische ÜbersichtOpen Access · CC BY-NC-ND 3.0

Nocturnal Enuresis is an Under-recognised Side Effect of Clozapine: Results of a Systematic Review

Niku Dhillon, Reinhard Heun

Global Psychiatry · 2018

DOI: 10.2478/gp-2018-0007 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Global Psychiatry, 2018. Verfasst von Niku Dhillon und 1 weiteren Autor:innen. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 3.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Clozapine is an effective antipsychotic medication licenced for the management of treatment resistant schizophrenia. Due to its non-selective pharmacology, it has a broad range of side effects. Nocturnal enuresis secondary to the use of clozapine has been documented in the literature but may be overlooked, the link between drug and symptom being clinically unnoticed. Patients may not mention urinary symptoms due to supervening psychosis, co-existing symptomatology, embarrassment or shame. By raising awareness of the phenomenon, early recognition and patient support may improve compliance with clozapine medication, and consecutively, overall mental health. Consequently, this systematic review investigates the prevalence of nocturnal enuresis secondary to clozapine use.

Methods

A literature search on clozapine and nocturnal enuresis was used to identify the relevant papers. Papers providing the prevalence data on Clozapine associated nocturnal enuresis were selected for data extraction.

Results

47 papers were initially identified. Eight papers focused on the prevalence of clozapine associated nocturnal enuresis (CANE). Point prevalence (nocturnal enuresis at the time of assessment), 1-month prevalence and episode prevalence (nocturnal enuresis since beginning of clozapine) were given. Papers included patients with schizophrenia, schizoaffective disorder, bipolar affective disorder and psychotic depression, taking clozapine medication. The prevalence of CANE ranged from 10–42%. Point prevalence was 21–27%, 1-month prevalence was 10–39% and episode prevalence was 15–42%. Clozapine was more likely to cause nocturnal enuresis compared to other psychotropic medication.

Conclusion

The prevalence of CANE may be greater than previously thought. However, in order to determine an accurate prevalence of clozapine associated nocturnal enuresis, larger studies with strict inclusion criteria, common definition of diagnosis and prevalence are required. By establishing an accurate prevalence, physician awareness can be improved, and patients can becounselled on the risk of developing the side effect, thus improving early identification and reducing discontinuation rates.

Zitieren

APA

Dhillon, N., & Heun, R. (2018). Nocturnal Enuresis is an Under-recognised Side Effect of Clozapine: Results of a Systematic Review. Global Psychiatry. https://doi.org/10.2478/gp-2018-0007

Vancouver

Dhillon N, Heun R. Nocturnal Enuresis is an Under-recognised Side Effect of Clozapine: Results of a Systematic Review. Global Psychiatry. 2018. doi:10.2478/gp-2018-0007

BibTeX
@article{Dhillon2018,
  author = {Dhillon, Niku and Heun, Reinhard},
  title = {Nocturnal Enuresis is an Under-recognised Side Effect of Clozapine: Results of a Systematic Review},
  journal = {Global Psychiatry},
  year = {2018},
  doi = {10.2478/gp-2018-0007}
}
Kostenlos starten →